Ionpath, a leader in high-definition spatial proteomics, announced the launch of MIBIslide Blue, a groundbreaking advancement in multimodal imaging. Featuring a proprietary optically transparent coating, MIBIslide Blue expands the capabilities of Ionpath’s MIBIscope™ imaging platform, enabling integration across genomics, transcriptomics, and proteomics workflows. Complementing the widely used MIBIslide™ Gold, this innovative slide marks a significant step forward in spatial biology by simplifying multi-omics analysis and enhancing imaging precision.
“MIBIslide Blue represents a significant leap forward in addressing imaging challenges with tissue types such as bone marrow, neural tissues, and porous samples, which have historically been difficult to study with high fidelity,” said Paul Davy, CEO of Ionpath. “With this launch, we reaffirm our commitment to empowering researchers to advance the field of spatial biology and bioinformatics, by turning spatial insights into actionable breakthroughs through precise data and high-quality imaging.”
By utilizing the same preparation protocols as MIBIslide™ Gold, MIBIslide Blue integrates into existing workflows, reducing complexity for researchers and ensuring a smooth transition. The slides’ compatibility with light microscopy further enables multimodal analysis, maximizing insights from every experiment.
Also Read: Ipsen & Biomunex Ink Exclusive Licensing Deal for MAIT Cell Engager
“We are using this new slide technology to push forward multimodal imaging workflows, combining MIBI with other mass spectrometry imaging techniques as well as conventional chromogenic stains,” said Sean Bendall, PhD, co-founder of Ionpath. “Its compatibility with light microscopy simplifies complex analyses, providing researchers with a robust tool to extract deeper insights from their experiments without the challenges of serial samples.”
Researchers worldwide are already using MIBIslide Blue to enhance their studies, integrating multimodal capabilities into their workflows.
“MIBIslide Blue is quickly becoming an indispensable tool in our lab, delivering unparalleled clarity and precision in spatial data acquisition,” said Felix J. Hartmann, PhD, Independent Junior Research Group Leader at the Systems Immunology and Single-Cell Biology Lab at Deutsches Krebsforschungszentrum. “Its integration with cross-platform multi-omics allows us to correlate spatial proteomics with complementary modalities, providing a robust framework for investigating complex biological systems.”
SOURCE: Businesswire